Format

Send to

Choose Destination
See comment in PubMed Commons below

Neurological manifestations of Fabry disease.

Editors

In: Mehta A1, Beck M2, Sunder-Plassmann G3, editors.

Source

Fabry Disease: Perspectives from 5 Years of FOS. Oxford: Oxford PharmaGenesis; 2006. Chapter 22.

Author information

1
Department of Academic Haematology, Royal Free and University College Medical School, London, UK
2
Universitäts-Kinderklinik, Mainz, Germany
3
Division of Nephrology and Dialysis, Department of Medicine III, Medical University Vienna, Vienna, Austria
4
Developmental and Metabolic Neurology Branch, National Institute of Neurological Disorders and Stroke, Building 10, Room 3D03, National Institutes of Health, Bethesda, Maryland, 20892-1260, USA
5
Section of Neurology, Department of Internal Medicine, University of Manitoba, Winnipeg, Canada

Excerpt

The neurological manifestations of Fabry disease include both peripheral nervous system and CNS involvement, with globotriaosylceramide accumulation found in Schwann cells and dorsal root ganglia together with deposits in CNS neurones. The main involvement of the CNS is attributable to cerebrovasculopathy, with an increased incidence of stroke. The abnormal neuronal accumulation of glycosphingolipid appears to have little clinical effect on the natural history of Fabry disease, with the possible exception of some reported mild cognitive abnormalities. The pathogenesis of Fabry vasculopathy remains poorly understood, but probably relates, in part, to abnormal functional control of the vessels, secondary to endothelial dysfunction as a consequence of α-galactosidase A deficiency. Obstructive vasculopathy, either primarily due to accumulation of glycolipid or secondary to consequent inflammation and confounding vascular risk factors, may develop in response to abnormal endothelial and vessel wall function, similar in some respects to that observed with accumulation of cholesterol-laden lipids during atherosclerosis. Involvement of the peripheral nervous system affects mainly small Aδ and C fibres, and is probably causally related to the altered autonomic function and neuropathic pain found in Fabry disease. Other related neurological problems include hypohidrosis and other abnormalities associated with nervous system dysfunction.

Copyright © 2006, Oxford PharmaGenesis™

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons
    Support Center